Arbutus Biopharma
Data Breaches, Cyber Attacks and Security Report
https://arbutusbio.com ᛫
Last updated November 12, 2019
https://arbutusbio.com ᛫
Last updated November 12, 2019
Arbutus Biopharma Corporation is a publicly traded (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania.
$525,589,900
Employees119
Burnaby, BC, Canada.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Arbutus Biopharma is implementing good security practices.
{{ passedCheck.passTitle }}
{{ failedCheck.failTitle }}Read more about the latest issues in cybersecurity
Compare Arbutus Biopharma's security performance with other companies